Implication of flowers and weeds in fibrosing alveolitis

Chronic obstructive pulmonary disease in Welsh slate miners.

Occupational medicine (Oxford, England)·2016

Bimodality in age of onset of psoriasis, in both patients and their relatives.

Dermatology (Basel, Switzerland)·1993

Concomitance of psoriasis and atopic dermatitis.

Dermatology (Basel, Switzerland)·1992

Knobbly granuloma annulare (GA) of the fingers of a milkman--a possible relationship to his work.

Clinical and experimental dermatology·1992

Basal-cell carcinoma of the breast--treatment with retinoids.

Clinical and experimental dermatology·1991

Aplasia cutis congenita presenting as a familial triad of atrophic alopecia, ocular defects and a peculiar scarring tendency of the skin.

The British journal of dermatology·1988

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Design, Synthesis, and Herbicidal Activity of Pyrimidinedione-Benzamide Derivatives as Potential Protoporphyrinogen IX Oxidase Inhibitors.

Journal of agricultural and food chemistry·2026

Pituitary Apoplexy Complicated by Pulmonary Embolism in a Neurologically Complex Patient: A Diagnostic Challenge.

Cureus·2026

Study on the biocontrol effectiveness of Bacillus velezensis XMAB21 against Alternaria alternata induced brown-spot disease in European plum (Prunus domestica L.).

3 Biotech·2026

Plant-derived nanovesicles in kidney disease: emerging preclinical evidence and translational challenges.

Frontiers in pharmacology·2026

Biocontrol efficacy of Trichoderma asperellum TA-1 against Rhizoctonia solani AG-3 and its underlying mechanisms.

Frontiers in microbiology·2026

Correction: Conserved RXLR effector genes of Phytophthora infestans expressed at the early stage of potato infection are suppressive to host defense.

Frontiers in plant science·2026

Related Experiment Videos

Implication of flowers and weeds in fibrosing alveolitis

Related Concept Videos

Chronic obstructive pulmonary disease in Welsh slate miners.

Bimodality in age of onset of psoriasis, in both patients and their relatives.

Concomitance of psoriasis and atopic dermatitis.

Knobbly granuloma annulare (GA) of the fingers of a milkman--a possible relationship to his work.

Basal-cell carcinoma of the breast--treatment with retinoids.

Aplasia cutis congenita presenting as a familial triad of atrophic alopecia, ocular defects and a peculiar scarring tendency of the skin.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Design, Synthesis, and Herbicidal Activity of Pyrimidinedione-Benzamide Derivatives as Potential Protoporphyrinogen IX Oxidase Inhibitors.

Pituitary Apoplexy Complicated by Pulmonary Embolism in a Neurologically Complex Patient: A Diagnostic Challenge.

Study on the biocontrol effectiveness of Bacillus velezensis XMAB21 against Alternaria alternata induced brown-spot disease in European plum (Prunus domestica L.).

Plant-derived nanovesicles in kidney disease: emerging preclinical evidence and translational challenges.

Biocontrol efficacy of Trichoderma asperellum TA-1 against Rhizoctonia solani AG-3 and its underlying mechanisms.

Correction: Conserved RXLR effector genes of Phytophthora infestans expressed at the early stage of potato infection are suppressive to host defense.

Related Experiment Videos

Implication of flowers and weeds in fibrosing alveolitis

Related Concept Videos

Related Articles